TTM | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Revenue | 6,592,100 | 6,074,500 | 5,681,100 | 5,265,200 | 5,122,200 |
| Cost of Revenue | -2,954,300 | -2,645,600 | -2,518,700 | -2,335,100 | -2,177,200 |
| Gross Profit | 3,637,800 | 3,428,900 | 3,162,400 | 2,930,100 | 2,945,000 |
| Selling, General and Administrative Expenses | -1,645,000 | -1,614,200 | -1,450,500 | -1,385,700 | -1,328,900 |
| Depreciation, Amortization and Depletion | -751,400 | -719,500 | -669,800 | -610,800 | -560,100 |
| Operating Income/Expenses | -2,396,400 | -2,333,700 | -2,120,300 | -1,996,500 | -1,889,000 |
| Total Operating Profit/Loss | 1,241,400 | 1,095,200 | 1,042,100 | 933,600 | 1,056,000 |
| Total Net Finance Income/Expense | -231,900 | -212,300 | -229,100 | -241,400 | -183,000 |
| Other Income/Expense, Non-Operating | 12,900 | 12,000 | -2,500 | 25,700 | 56,700 |
| Non-Operating Income/Expenses, Total | -219,000 | -200,300 | -231,600 | -215,700 | -126,300 |
| Pretax Income | 1,022,400 | 894,900 | 810,500 | 717,900 | 929,700 |
| Provision for Income Tax | -274,200 | -230,600 | -203,200 | -166,200 | -229,500 |
| Net Income from Continuing Operations | 748,200 | 664,300 | 607,300 | 551,700 | 700,200 |
| Net Income after Extraordinary Items and Discontinued Operations | 748,200 | 664,300 | 607,300 | 551,700 | 700,200 |
| Non-Controlling/Minority Interests | -5,300 | -4,000 | -3,200 | -6,400 | -4,000 |
| Net Income after Non-Controlling/Minority Interests | 742,900 | 660,300 | 604,100 | 545,300 | 696,200 |
| Net Income Available to Common Stockholders | 742,900 | 660,300 | 604,100 | 545,300 | 696,200 |
| Diluted Net Income Available to Common Stockholders | 742,900 | 660,300 | 604,100 | 545,300 | 696,200 |
| Common Dividend per Share | 2.18 | 1.89 | 1.56 | 1.56 | 1.56 |
| Basic EPS | 6.23 | 5.36 | 4.88 | 4.44 | 5.69 |
| Diluted EPS | 6.19 | 5.32 | 4.84 | 4.40 | 5.65 |
| Basic Weighted Average Shares Outstanding | 119,375 | 123,200 | 123,800 | 122,900 | 122,400 |
| Diluted Weighted Average Shares Outstanding | 120,050 | 124,100 | 124,900 | 123,900 | 123,300 |
| Reported Normalized Diluted EPS | 7.99 | 124.10 | 7.29 | 6.71 | 7.56 |
| Income Statement, Supplemental | |||||
| EBIT | 1,254,300 | 1,107,200 | 1,039,600 | 959,300 | 1,112,700 |
| EBITDA | 2,013,000 | 1,834,100 | 1,720,200 | 1,579,100 | 1,681,300 |
| Normalized EBITDA | 2,102,000 | 1,935,300 | 1,836,100 | 1,693,600 | 1,721,600 |
| Normalized Income | 813,330.91 | 949,200 | 910,100 | 831,500 | 932,600 |
| Total Unusual Items | 89,000 | 77,200 | 81,600 | 58,000 | 25,800 |
| Total Unusual Items Excluding Goodwill | 89,000 | 77,200 | 81,600 | 58,000 | 25,800 |
| Tax Effect of Unusual Items | 23,869.09 | 19,917.60 | 20,481.60 | 13,456 | 6,372.60 |
| Tax Rate, Calculated | 0.27 | 0.26 | 0.25 | 0.23 | 0.25 |
NYSE - Delayed Quote USD
Equifax Inc. (EFX)
177.19 +0.68 (+0.39%)
At close: November 20 at 4:00:02 PM EST
177.19 0.00 (0.00%)
After hours: November 20 at 5:23:45 PM EST